Abstract
To discuss what is currently known about myocarditis in the context of major connective tissue diseases, including Systemic lupus erythematosus, Rheumatoid Arthritis, Sjogren, Dermato-myositis and Polymyositis, Systemic Sclerosis, and Mixed connective tissue disease. Variability exists between studies regarding the incidence of myocarditis in connective tissue diseases, which is hypothesized to be the result of its subclinical course in most cases. Extensive gaps of knowledge exist in the field of pathophysiology. Although endomyocardial biopsy remains to be the gold standard for diagnosis, the advancement in non-invasive modalities such as cardiac MRI, echocardiography, and nuclear medicine has allowed for earlier and more frequent detection of myocarditis. A lack of treatment guidelines was found across the different connective tissue diseases. Most of the literature available revolved around myocarditis in the context of Systemic lupus erythematosus. Numerous recent studies were published that contributed to advancements in diagnosis and treatment however, there remains a lack of diagnostic and treatment guidelines.
Similar content being viewed by others
References
Pepmueller PH (2006) Undifferentiated connective tissue disease, mixed connective tissue disease, and overlap syndromes in rheumatology. Mo Med 113:136–140
Stougiannos PN, Mytas DZ, Katsaros AA, Kakkavas AT, Androulakis AE, Kallikazaros IE, Chrissos DN (2009) Chest pain and ST-segment elevation in a patient with polymyositis: a case report. Cases J 2:84
Rose NR (2016) Viral myocarditis. Curr Opin Rheumatol 2016(28):383–389
Rose NR, Neumann DA, Herskowitz A (1992) Coxsackievirus myocarditis. Adv Intern Med 37:411–429
Garg A, Shiau J, Guyatt G (1998) The ineffectiveness of immunosuppressive therapy in lymphocytic myocarditis: an overview. Ann Intern Med 129:317–322
Rose NR (2009) Myocarditis: infection versus autoimmunity. J Clin Immunol 29:730–737
Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R et al (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34:2636–2648, 2648a–2648d
Villablanca P, Mohananey D, Meier G, Yap JE, Chouksey S, Abegunde AT (2015) Salmonella berta myocarditis: case report and systematic review of non-typhoid salmonella myocarditis. World J Cardiol 7:931–937
Childs L, Gupta S (2012) Salmonella enteritidis induced myocarditis in a 16-year-old girl. BMJ Case Rep. https://doi.org/10.1136/bcr-2012-007628
Van Diem L, Arnold K (1974) Typhoid fever with myocarditis. Am J Trop Med Hyg 23:218–221
Hidron A, Vogenthaler N, Santos-Preciado JI, Rodriguez-Morales AJ, Franco-Paredes C, Rassi AJ (2010) Cardiac involvement with parasitic infections. Clin Microbiol Rev 23:324–349
Pandey S, Rajasurya V (2023) Nonviral myocarditis. StatPearls Publishing, Treasure Island
Mavrogeni SI, Kitas GD, Dimitroulas T, Sfikakis PP, Seo P, Gabriel S, Patel AR, Gargani L, Bombardieri S, Matucci-Cerinic M et al (2016) Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use. Int J Cardiol 217:135–148
Podlesnikar T, Lapinskas T (2019) Cardiac involvement in connective tissue disorders: terra incognita. JACC Case Rep 1:243–245
Ozierański K, Tymińska A, Kobylecka M, Caforio ALP, Šobić-Šaranović D, Ristić AD, Maksimović R, Seferović PM, Marcolongo R, Królicki L et al (2021) Positron emission tomography in clinically suspected myocarditis—STREAM study design. Int J Cardiol 332:113–118
Justiz Vaillant AA, Goyal A, Varacallo M (2022) Systemic lupus erythematosus. StatPearls Publishing, Treasure Island
Jain D, Halushka MK (2009) Cardiac pathology of systemic lupus erythematosus. J Clin Pathol 62:584–592
Badui E, Garcia-Rubi D, Robles E, Jimenez J, Juan L, Deleze M, Diaz A, Mintz G (1985) Cardiovascular manifestations in systemic lupus erythematosus. prospective study of 100 patients. Angiology 36:431–441
Tincani A, Rebaioli CB, Taglietti M, Shoenfeld Y (2006) Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology (Oxford) 45:iv8–iv13
Cheng C-Y, Baritussio A, Giordani AS, Iliceto S, Marcolongo R, Caforio ALP (2022) Myocarditis in systemic immune-mediated diseases: prevalence, characteristics and prognosis. A systematic review. Autoimmun Rev 21:103037
Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH (1954) Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 33:291–437
Estes D, Christian CL (1971) The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 50:85–95
Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT (2021) Update οn the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis 80:14–25
Winau L, HinojarBaydes R, Braner A, Drott U, Burkhardt H, Sangle S, D’Cruz DP, Carr-White G, Marber M, Schnoes K et al (2018) High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus. Ann Rheum Dis 77:1590–1598
Burkard T, Trendelenburg M, Daikeler T, Hess C, Bremerich J, Haaf P, Buser P, Zellweger MJ (2018) The heart in systemic lupus erythematosus—a comprehensive approach by cardiovascular magnetic resonance tomography. PLoS One 13:e0202105
Bulkley BH, Roberts WC (1975) The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med 58:243–264
Bidani AK, Roberts JL, Schwartz MM, Lewis EJ (1980) Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 69:849–858
Das SK, Cassidy JT (1975) Antiheart antibodies in patients with systemic lupus erythematosus. Am J Med Sci 265:275–280
Lash AD, Wittman AL, Quismorio FPJ (1986) Myocarditis in mixed connective tissue disease: clinical and pathologic study of three cases and review of the literature. Semin Arthritis Rheum 15:288–296
Logar D, Kveder T, Rozman B, Dobovisek J (1990) Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann Rheum Dis 49:627–629
Tanwani J, Tselios K, Gladman DD, Su J, Urowitz MB (2018) Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies. Lupus 27:1296–1302
Thomas G, Cohen Aubart F, Chiche L, Haroche J, Hié M, Hervier B, Costedoat-Chalumeau N, Mazodier K, Ebbo M, Cluzel P et al (2017) Lupus myocarditis: initial presentation and longterm outcomes in a multicentric series of 29 patients. J Rheumatol 44:24–32
Du Toit R, Herbst PG, van Rensburg A, du Plessis LM, Reuter H, Doubell AF (2017) Clinical features and outcome of lupus myocarditis in the Western Cape, South Africa. Lupus 26:38–47
Zawadowski GM, Klarich KW, Moder KG, Edwards WD, Cooper LTJ (2012) A contemporary case series of lupus myocarditis. Lupus 21:1378–1384
Law WG, Thong BY, Lian TY, Kong KO, Chng HH (2005) Acute lupus myocarditis: clinical features and outcome of an oriental case series. Lupus 14:827–831
Ansari A, Larson PH (1985) Heart disease in systemic lupus erythematosus: diagnosis and management. Texas Hear Inst J 12:9–21
Manautou L, Jerjes-Sanchez C, Meraz M, Perez-Garcia LF, Diaz-Cid A, de la Peña-Almaguer E, Avila C, Sanchez L (2014) Myopericarditis with predominantly right ventricular involvement with normal B-type natriuretic peptide and cardiac tamponade as the initial manifestation of systemic lupus erythematosus. Lupus 23:935–938
Zhang L, Zhu Y-L, Li M-T, Gao N, You X, Wu Q-J, Su J-M, Shen M, Zhao L-D, Liu J-J et al (2015) Lupus myocarditis: a case–control study from China. Chin Med J (Engl) 128:2588–2594
Chung J-W, Joe D-Y, Park H-J, Kim H-A, Park H-S, Suh C-H (2008) Clinical characteristics of lupus myocarditis in Korea. Rheumatol Int 28:275–280
Neto A, Torres S, Pissarra D, Vasconcelos G (2021) Myocardial rupture and systemic lupus erythematosus: a case report. Eur Heart J Case Rep 5:ytaa458
Mavrogeni S, Dimitroulas T, Kitas GD (2012) Multimodality imaging and the emerging role of cardiac magnetic resonance in autoimmune myocarditis. Autoimmun Rev 12:305–312
Alchammas J, Al-Faham Z, Roumayah Y, Wong OCY (2016) The evaluation of lupus myocarditis with 13N-ammonia and 18F-FDG PET. J Nucl Med Technol 44:210–211
Wijetunga M, Rockson S (2002) Myocarditis in systemic lupus erythematosus. Am J Med 113:419–423
Caforio ALP, Adler Y, Agostini C, Allanore Y, Anastasakis A, Arad M, Böhm M, Charron P, Elliott PM, Eriksson U et al (2017) Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J 38:2649–2662
Borenstein DG, Fye WB, Arnett FC, Stevens MB (1978) The myocarditis of systemic lupus erythematosus: association with myositis. Ann Intern Med 89:619–624. https://doi.org/10.7326/0003-4819-89-5-619
Naarendorp M, Kerr LD, Khan AS, Ornstein MH (1999) Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of 6 cases. J Rheumatol 26:2257–2260
Chan YK, Li EK, Tam LS, Chow LTC, Ng HK (2003) Intravenous cyclophosphamide improves cardiac dysfunction in lupus myocarditis. Scand J Rheumatol 32:306–308
Micheloud D, Calderón M, Caparrros M, D’Cruz DP (2007) Intravenous immunoglobulin therapy in severe lupus myocarditis: good outcome in three patients. Ann Rheum Dis 66:986–987
Sherer Y, Levy Y, Shoenfeld Y (1999) Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 18:238–240
Gottenberg J-E, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M et al (2005) Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis 64:913–920
Mohanty B, Sunder A (2020) Lupus myocarditis—a rare case. J Fam Med Prim Care 9:4441–4443
Meier FMP, Frommer KW, Dinser R, Walker UA, Czirjak L, Denton CP, Allanore Y, Distler O, Riemekasten G, Valentini G et al (2012) Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research Group database. Ann Rheum Dis 71:1355–1360
Cutolo M, Sulli A, Pizzorni C, Paolino S, Smith V (2016) Systemic sclerosis: markers and targeted treatments. Acta Reumatol Port 41:18–25
Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, Bullo A, Cazzato M, Tirri E, Storino F et al (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81:139–153
Vanthuyne M, Smith V, De Langhe E, Van Praet J, Arat S, Depresseux G, Westhovens R, Blockmans D, Badot V, Cogan E et al (2012) The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile. J Rheumatol 39:2127–2133
Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Müller-Ladner U, Distler O et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:1809–1815
Vandecasteele EH, De Pauw M, Brusselle G, Decuman S, Piette Y, De Keyser F, Smith V (2016) The heart and pulmonary arterial hypertension in systemic sclerosis. Acta Clin Belg 71:1–18
Janosik DL, Osborn TG, Moore TL, Shah DG, Kenney RG, Zuckner J (1989) Heart disease in systemic sclerosis. Semin Arthritis Rheum 19:191–200
Lambova SC (2014) Manifestations in systemic sclerosis. World J Cardiol 6:993–1005
Allanore Y, Avouac J, Kahan A (2008) Systemic sclerosis: an update in 2008. Jt Bone Spine 75:650–655
Ferri C, Giuggioli D, Sebastiani M, Colaci M, Emdin M (2005) Heart involvement and systemic sclerosis. Lupus 14:702–707
Pussadhamma B, Tipparot T, Chaosuwannakit N, Mahakkanukrauh A, Suwannaroj S, Nanagara R, Foocharoen C (2020) Clinical outcomes of myocarditis after moderate-dose steroid therapy in systemic sclerosis: a pilot study. Int J Rheumatol. https://doi.org/10.1155/2020/8884442
McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in Collaboration with the Hear. Eur J Heart Fail 14:803–869
Follansbee WP, Curtiss EI, Medsger TAJ, Steen VD, Uretsky BF, Owens GR, Rodnan GP (1984) Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 310:142–148
Follansbee WP, Curtiss EI, Medsger TAJ, Owens GR, Steen VD, Rodnan GP (1984) Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. exercise radionuclide evaluation and comparison with diffuse scleroderma. Am J Med 77:489–496
Deswal A, Follansbee WP (1996) Cardiac involvement in scleroderma. Rheum Dis Clin North Am 22:841–860
Pieroni M, De Santis M, Zizzo G, Bosello S, Smaldone C, Campioni M, De Luca G, Laria A, Meduri A, Bellocci F et al (2014) Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression. Semin Arthritis Rheum 43:526–535
Siegel RJ, O’Connor B, Mena I, Criley JM (1984) Left ventricular function at rest and during Raynaud’s phenomenon in patients with scleroderma. Am Heart J 108:1469–1476
Allanore Y, Meune C, Vignaux O, Weber S, Legmann P, Kahan A (2006) Bosentan increases myocardial perfusion and function in systemic sclerosis: a magnetic resonance imaging and tissue-Doppler echography study. J Rheumatol 33:2464–2469
Jakubaszek M, Kwiatkowska B, Maślińska M (2015) Polymyositis and dermatomyositis as a risk of developing cancer. Reumatologia 53:101–105
Zhang L, Wang G, Ma L, Zu N (2012) Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol 35:686–691
Dankó K, Ponyi A, Constantin T, Borgulya G, Szegedi G (2004) Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine (Baltimore) 83:35–42
Schiopu E, Phillips K, MacDonald PM, Crofford LJ, Somers EC (2012) Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine. Arthritis Res Ther 14:R22
Bazzani C, Cavazzana I, Ceribelli A, Vizzardi E, Dei Cas L, Franceschini F (2010) Cardiological features in idiopathic inflammatory myopathies. J Cardiovasc Med (Hagerstown) 11:906–911
Haupt HM, Hutchins GM (1982) The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients. Am J Cardiol 50:998–1006
Denbow CE, Lie JT, Tancredi RG, Bunch TW (1979) Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients. Arthritis Rheum 22:1088–1092
Lundberg IE (2006) The heart in dermatomyositis and polymyositis. Rheumatology (Oxford) 45:iv18–iv21
Lie JT (1995) Cardiac manifestations in polymyositis/dermatomyositis: how to get to heart of the matter. J Rheumatol 22:809–811
Taylor AJ, Wortham DC, Burge JR, Rogan KM (1993) The heart in polymyositis: a prospective evaluation of 26 patients. Clin Cardiol 16:802–808
Péter A, Balogh Á, Szilágyi S, Faludi R, Nagy-Vincze M, Édes I, Dankó K (2015) Echocardiographic abnormalities in new-onset polymyositis/dermatomyositis. J Rheumatol 42:272–281
Erlacher P, Lercher A, Falkensammer J, Nassonov EL, Samsonov MI, Shtutman VZ, Puschendorf B, Mair J (2001) Cardiac troponin and beta-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis. Clin Chim Acta 306:27–33
Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS (1995) Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem 41:1710–1715
Hengstman GJD, ter Laak HJ, Vree Egberts WTM, Lundberg IE, Moutsopoulos HM, Vencovsky J, Doria A, Mosca M, van Venrooij WJ, van Engelen BGM (2006) Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis 65:1635–1638
Brouwer R, Hengstman GJ, Vree Egberts W, Ehrfeld H, Bozic B, Ghirardello A, Grøndal G, Hietarinta M, Isenberg D, Kalden JR et al (2001) Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 60:116–123
Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70:360–374
Okada Y, Takakuwa Y, Ooka S, Ogawa Y, Kawahata K, Kobayashi Y, Yamaguchi K, Akashi Y (2021) Usefulness of 123I-BMIPP and 201TlCl nuclide scintigraphy in evaluation of myocarditis in patients with polymyositis or dermatomyositis. Medicine (Baltimore) 100:e27173
Shigematsu T, Okayama H, Hiasa G, Kazatani Y (2016) (18)F-Fluorodeoxyglucose positron emission tomography for the diagnosis of myocarditis associated with polymyositis. Circ J 81:121–122
Ohata S, Shimada T, Shimizu H, Murakami Y, Matsuno Y (2002) Myocarditis associated with polymyositis diagnosed by gadolinium-DTPA enhanced magnetic resonance imaging. J Rheumatol 29:861–862
Allanore Y, Vignaux O, Arnaud L, Puéchal X, Pavy S, Duboc D, Legmann P, Kahan A (2006) Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Ann Rheum Dis 65:249–252
Barbasso Helmers S, Dastmalchi M, Alexanderson H, Nennesmo I, Esbjörnsson M, Lindvall B, Lundberg IE (2007) Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies. Ann Rheum Dis 66:1276–1283
Cheston HJ, Akhoon C, Dutta Roy S, Reynolds P (2022) Managing myocarditis in a patient with newly diagnosed dermatomyositis. BMJ Case Rep 15:e246989
Touma Z, Arayssi T, Kibbi L, Masri AF (2008) Successful treatment of cardiac involvement in dermatomyositis with rituximab. Jt Bone Spine 75:334–337
Afzal A, Higgins RS, Philbin EF (1999) Heart transplant for dilated cardiomyopathy associated with polymyositis. Heart 82:e4
Ntusi NAB, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, Wordsworth PB, Neubauer S, Karamitsos TD (2015) Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping. JACC Cardiovasc Imaging 8:526–536
Sigal LH, Friedman HD (1989) Rheumatoid pancarditis in a patient with well controlled rheumatoid arthritis. J Rheumatol 16:368–373
Howlett JG, McKelvie RS, Arnold JMO, Costigan J, Dorian P, Ducharme A, Estrella-Holder E, Ezekowitz JA, Giannetti N, Haddad H et al (2009) Canadian Cardiovascular Society consensus conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol 25:85–105
Amigues I, Tugcu A, Russo C, Giles JT, Morgenstein R, Zartoshti A, Schulze C, Flores R, Bokhari S, Bathon JM (2019) Myocardial inflammation, measured using 18-fluorodeoxyglucose positron emission tomography with computed tomography, is associated with disease activity in rheumatoid arthritis. Arthritis Rheumatol (Hoboken, N.J.) 71:496–506
Slack JD, Waller B (1986) Acute congestive heart failure due to the arteritis of rheumatoid arthritis: early diagnosis by endomyocardial biopsy: a case report. Angiology 37:477–482
Kwon HJ, Coté TR, Cuffe MS, Kramer JM, Braun MM (2003) Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med 138:807–811
Liang M, Bao L, Xiong N, Jin B, Ni H, Zhang J, Zou H, Luo X, Li J (2015) Cardiac arrhythmias as the initial manifestation of adult primary Sjögren’s syndrome: a case report and literature review. Int J Rheum Dis 18:800–806
Inoue H, Kinoshita K, Sugiyama M, Funauchi M, Hanagama M, Nata M (2008) Sudden death from ischaemic heart disease in a female patient with Sjögren syndrome: a case report. Med Sci Law 48:261–265
Levin MD, Zoet-Nugteren SK, Markusse HM (1999) Myocarditis and primary Sjögren’s syndrome. Lancet (London, England) 354:128–129
Watanabe T, Takahashi Y, Hirabayashi K, Tomaru U, Machida M (2019) Acute fulminant myocarditis in a patient with primary Sjögren’s syndrome. Scand J Rheumatol 48:164–165
Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR (1972) Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148–159
Alves MR, Isenberg DA (2020) “Mixed connective tissue disease”: a condition in search of an identity. Clin Exp Med 20:159–166
Cappelli S, Bellando Randone S, Martinović D et al (2012) ‘To be or not to be’, ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum 41:589–598
Ungprasert P, Wannarong T, Panichsillapakit T, Cheungpasitporn W, Thongprayoon C, Ahmed S, Raddatz DA (2014) Cardiac involvement in mixed connective tissue disease: a systematic review. Int J Cardiol 171:326–330
Alpert MA, Goldberg SH, Singsen BH et al (1983) Cardiovascular manifestations of mixed connective tissue disease in adults. Circulation 68:1182–1193
Oetgen WJ, Mutter ML, Lawless OJ et al (1983) Cardiac abnormalities in mixed connective tissue disease. Chest 83:185–188
Leung WH, Wong KL, Lau CP et al (1990) Echocardiographic identification of mitral valvular abnormalities in patients with mixed connective tissue disease. J Rheumatol 17:485–488
Burdt MA, Hoffman RW, Deutscher SL et al (1999) Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 42:899–909
Hajas A, Szodoray P, Nakken B et al (2013) Clinical course prognosis and causes of death in mixed connective tissue disease. J Rheumatol 40:1134–1142
Rebollar-González V, Torre-Delgadillo A, Orea-Tejeda A et al (2001) Cardiac conduction disturbances in mixed connective tissue disease. Rev Investig Clin 53:330–334
Whitlow PL, Gilliam JN, Chubick A, Ziff M (1980) Myocarditis in mixed connective tissue disease. Association of myocarditis with antibody to nuclear ribonucleoprotein. Arthritis Rheum 23:808–815
Author information
Authors and Affiliations
Contributions
MA, AA, AG, BK have contributed to the conceptualization and design of the work. MA, AA, AG, BK have participated in drafting and revising of the intellectual content. All authors have read and agreed to the final version of the manuscript. All authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Azzam, M., Awad, A., Abugharbyeh, A. et al. Myocarditis in connective tissue diseases: an often-overlooked clinical manifestation. Rheumatol Int 43, 1983–1992 (2023). https://doi.org/10.1007/s00296-023-05428-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-023-05428-w